A comprehensive view of Bristol-Myers Squibb Co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bristol-Myers focuses on cardiovascular health education, collaborates with international associations for hypertrophic cardiomyopathy awareness, and highlights the role of community in cancer treatment; company also emphasizes mentorship in its R&D teams

Bristol Myers Squibb Co and Scripps Research Inst Seek Patent for Systems and Methods of Selecting Compounds That Induce Conformational Changes in Mutant Cereblon

'Cancer Immunotherapy By Disrupting Pd-1/Pd-L1 Signaling' in Patent Application Approval Process (USPTO 20240034793)

Bristol-Myers Squibb Co. Bolsters Industry Presence with Hypertrophic Cardiomyopathy Event and Pioneers Digital Learning and Cancer Research Initiatives

FDA accepts Bristol Myers’ supplemental new drug application for Krazati adagrasib combined with Cetuximab for priority review; the targeted treatment is meant for patients with previously treated KRASG12C-mutated colorectal cancer

Ask us about our Bioeconomy market view

Trending Chart

Interactive chart with headline count